We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+27.96%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
AUM
$514M
AUM Growth
-$45.1M
Cap. Flow
-$126M
Cap. Flow %
-24.6%
Top 10 Hldgs %
70.54%
Holding
81
New
6
Increased
6
Reduced
6
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 21.54%
2 Miscellaneous 17.39%
3 Industrials 14.37%
4 Consumer Discretionary 11.57%
5 Materials 9.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLD icon
1
SPDR Gold Trust
GLD
$148B
$84.7M 16.49%
475,000
DRRX
2
DELISTED
DURECT Corp
DRRX
$54.7M 10.64%
2,641,466
LIN icon
3
Linde
LIN
$216B
$50.8M 9.88%
192,627
BC icon
4
Brunswick
BC
$4.66B
$38.1M 7.42%
500,000
+193,901
+63% +$13.7M
IVAC
5
DELISTED
Intevac Inc
IVAC
$35.7M 6.95%
4,949,355
IDN icon
6
Intellicheck
IDN
$55.3M
$26.6M 5.17%
2,328,678
-409,636
-15% -$3.69M
OPTU
7
Optimum Communications Inc
OPTU
$377M
$22.9M 4.45%
603,600
INVE icon
8
Identive
INVE
$65M
$18.7M 3.63%
2,196,389
LIQT icon
9
LiqTech
LIQT
$21.8M
$17.3M 3.36%
269,806
SPGI icon
10
S&P Global
SPGI
$127B
$13.1M 2.56%
40,000
CDXS icon
11
Codexis
CDXS
$157M
$12.6M 2.46%
579,116
GRA
12
DELISTED
W.R. Grace & Co.
GRA
$11M 2.14%
200,934
LSXMK
13
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$10.3M 2%
305,187
THO icon
14
Thor Industries
THO
$3.86B
$10.2M 1.99%
109,753
RPRX icon
15
Royalty Pharma
RPRX
$27B
$10M 1.95%
200,000
-915,980
-82% -$38.9M
SHLX
16
DELISTED
Shell Midstream Partners, L.P.
SHLX
$9.21M 1.79%
913,347
FATE icon
17
Fate Therapeutics
FATE
$300M
$9.09M 1.77%
100,000
MRNS
18
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$8.69M 1.69%
712,500
+132,038
+23% +$1.84M
NS
19
DELISTED
NuStar Energy L.P.
NS
$6.28M 1.22%
435,500
BX icon
20
Blackstone
BX
$101B
$5.18M 1.01%
80,000
NGL icon
21
NGL Energy Partners
NGL
$2.19B
$5.07M 0.99%
2,112,695
-602,242
-22% -$1.79M
LSXMA
22
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$4.47M 0.87%
141,002
TGTX icon
23
TG Therapeutics
TGTX
$8.53B
$3.9M 0.76%
75,000
+5,000
+7% +$169K
JPM icon
24
JPMorgan Chase
JPM
$940B
$3.81M 0.74%
30,000
DNTH icon
25
Dianthus Therapeutics
DNTH
$6.1B
$3.41M 0.66%
27,150
+5,158
+23% +$585K

Similar funds

Bleichroeder LP's Q4 2020 Portfolio in Review

As of Q4 2020, Bleichroeder LP held 81 positions worth $514M, down 8.1% from $559M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Bleichroeder LP withdrew a net $126M in Q4 2020, closing 9 positions and reducing 6 holdings. Its most notable exit was DCP Midstream, LP, an estimated $31.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Industrials.

Against the trend, Bleichroeder LP opened a new position in Healthcare Services Acquisition Corporation Unit worth $1.53M.

  • Bleichroeder LP's largest Q4 2020 buy was Healthcare Services Acquisition Corporation Unit: 150,000 shares worth $1.53M.
  • Bleichroeder LP added most to Brunswick in Q4 2020, an estimated $13.7M increase.
  • Bleichroeder LP's biggest Q4 2020 reduction was Royalty Pharma, cutting an estimated $38.9M.
  • Bleichroeder LP fully exited DCP Midstream, LP in Q4 2020, selling an estimated $31.8M.
  • Bleichroeder LP's ten largest holdings make up 71% of its $514M portfolio in Q4 2020.
  • Bleichroeder LP opened 6 new positions and closed 9 in Q4 2020.
  • Bleichroeder LP's portfolio value fell 8.1% quarter-over-quarter to $514M.

Based on Bleichroeder LP's 13F filing for Q4 2020, filed 10 Feb 2021.